Skip to main content

PLTR stock forecast 2025： Cathie Woods increased Palantir stock position

Pltr

Software company Palantir (PLTR) released the latest quarterly earnings report, which performed very well.


 After the financial report, Palantir's stock price soared to 14.64% at the highest point. At the same time, the keen Cathie Woods also bought $140 million in Palantir stock.


 I won't talk about Palantir's specific business. If you don't know much about it, you can go back to my previous article.  Let's talk back to the financial report.  Benefiting from the benefits of the US government’s contract renewal, Palantir’s earnings per share and total revenue both beat expectations for this quarter’s earnings report.  Among them, earnings per share were $0.04, beating the expected $0.01; total revenue was 376 million, an increase of 49% from the same period last year, slightly higher than the expected $361 million.  Although the extent of beating expectations is not very large, the biggest highlight of the financial report is to broaden the business. 


 The value of Palantir's new contracts this quarter increased by a staggering 175% year-on-year, reaching US$925 million.  The number of business users that the market is particularly concerned about, that is, non-government customers increased by 32% from the previous quarter and 61% from the beginning of this year, which means that Palantir is being accepted by more and more enterprise users.


 The highlights of the Palantir financial report this time can be said to be fully in line with the underlying logic of Cathie Woods investing in it.


 In an interview in February this year, Cathie Woods once said that Palantir is deeply plowing in a unique market, and there will be long-term development in the next 10 years.  At the same time, she believes that many high-end technologies originate from government applications, and 61% of Palantir's revenue comes from the government, indicating the reliability of Palantir's technology.  In this financial report, Palantir received a large number of commercial orders, which made investors more affirmed that Palantir can continue to expand the market and get rid of the dilemma of over-reliance on government orders.


 It also allowed the market to promise the CEO the 30% annualized profit growth rate.  More optimistic.  Compared with Cathie Woods in an interview in February, Palantir is now not only cheaper, but the fundamentals are also more solid, so it's no surprise that we see Cathie Woods buying its shares aggressively.  Currently, Palantir is already the 15th largest position of ARK.


 After the financial report came out, Wall Street also updated their views.


 Among them, RBC gave a target price of $25 and rated Palantir as "outperformed the market."  RBC believes that while Palantir will increase government orders in the next quarter, orders for more important commercial customers will also increase a lot. They are confident that Palantir will double the number of commercial customers before the end of the year.  However, there are also bearish voices in the market. 


Analysts at Morgan Stanley only gave a target price of $22, which means there is a 12% downside from the present, and gave a rating of "under the market".  Morgan Stanley's biggest concern is that Palantir's contract growth rate may not continue.  Analysts of the bank pointed out that 90% of the 175% revenue growth in the quarter came from customers who have strategic investment relationships with Palantir, and they believe that such a growth rate is unsustainable.


 Is optimistic about Palantir's long-term development potential in the future.


 As I said in the previous article, Palantir’s advantage lies in its vast market, deep moat, and attractive growth potential. If you look at this company from a 10-year perspective, I think it will be a  Very good investment target.  Although the valuation of PLTR may not be cheap, I think Palantir's potential is worthy of the valuation premium.  However, as I have always said, the uncertainty facing growth stocks in the short term is increasing. If you don't have a long-term investment vision, you need to be cautious about starting growth stocks like Palantir now.

Labels:

Comments

Post a Comment

Popular posts from this blog

Moderna stock forecast 2025： MRNA is worth buying for 5 reasons

Moderna was founded in 2009 and was established in Cambridge, Massachusetts, USA. Its main business is genetic engineering and focuses on the research and development of mRNA-derived drugs. The full name of mRNA is messenger RNA, pre-messenger RNA, a kind of immature single-stranded messenger ribonucleic acid, once it is completely processed, it is called "mature messenger RNA", or "mRNA". These drugs use mRNA as a treatment method and use mRNA as the basis to inject the developed synthetic mRNA into the patient's body so that the patient's own cells can obtain the ability to treat themselves. At present, the new crown vaccine being researched and developed by Moderna has an effective rate of 94.5%, so it has become one of the vaccines that are sold in large quantities all over the world. Cambridge, Massachusetts, is not only home to Harvard University but also a world-renowned hot spot for modern biomedicine. Despite such a "gorgeous background", ...
Post a Comment
Read more

NIO vs LI vs XPEV stock： Q1 financial report analysis

Q1 financial report analysis： NIO vs LI vs XPEV stock  In the financial report, the most striking thing is the delivery volume.  Comprehensive data shows that the NIO Q1 delivery volume exceeded 20,000 for the first time and continued to lead.  Beginning in 2021, NIO set a record of 20,060 deliveries in the first quarter, an increase of 422.7% year-on-year.  All aspects of XPEV can be described as "stable".  The delivery of LI decreased by 13.03% month-on-month, making it the only company among the top three automakers that had a negative growth rate from the previous month.    At the same time, the financial report showed that after achieving profit in the previous quarter, LI Q1 turned into a loss.  The net loss reached 360 million yuan, an increase of 366.9% year-on-year.  It is not difficult to see that the gap between LI Auto and the other two companies has not narrowed.  At the same time, in the car-making boom, the market's v...
Post a Comment
Read more

C3.ai stock forecast 2025: Is it time to buy now?

  Few emerging technologies are as exciting as artificial intelligence. We have witnessed its ability to be applied in new ways, from quickly analyzing large amounts of data to improve the efficiency of hardware and software. C3.ai(AI) is one of the only companies in the world that develop artificial intelligence into independent services. In short, artificial intelligence is its entire business.  Investors avoided such stocks this year because large technology companies began to engage in artificial intelligence projects, raising concerns about increased competitive threats.  However, C3.ai continued to increase revenue, narrowed its losses, and added 82% of its customers in the fourth quarter of fiscal 2021. Therefore, the stock price has fallen about 60% so far this year, which may be a huge opportunity for those who want to get involved in this field.  A unique business case  Imagine that if a company needs to develop its own artificial intelligence, sim...
Post a Comment
Read more